Saskia Middeldorp: The Use of LMWH in Women With Pregnancy Complications
Saskia Middeldorp, Head and Professor of Internal Medicine at Radboudumc, shared a post on LinkedIn about a recent article by her, published in JTH, adding:
“In this commentary in Journal of Thrombosis and Haemostasis on the GROWTH trial, I summarize the lack of evidence, and the evidence of absence of effect, on the use of heparin LMWH for women with pregnancy complications. Thanks to all investigators who remain persistent on getting high-quality evidence that women deserve so much.
It has taken way too long to say goodbye to a promise of heparin that has never been firmly delivered but does harm patients with the burden of injections, costs, and false hope.”
Title: It is time to accept the painful truth: low-molecular-weight heparin does not improve outcomes in women with pregnancy complications
Authors: Saskia Middeldorp
Stay updated with Hemostatis Today.
-
Nov 3, 2026, 13:37Godfred Oduro: Engaging Young Students in Thalassemia and Sickle Cell Disease Awareness
-
Nov 3, 2026, 13:31Nita Radhakrishnan: MRI T2 Reveals Hidden Cardiac and Hepatic Iron Overload in Thalassemia
-
Nov 3, 2026, 13:26Chancellor Donald: Bridging Hematology Innovation and Entrepreneurship to Advance Patient Care
-
Nov 3, 2026, 13:21Pete Stibbs: From Scientific Ideas to Clinical Impact
-
Nov 3, 2026, 13:06Backflow-Induced Clot Formation During Red Cell Transfusion – AABB
-
Nov 3, 2026, 12:38Kemal Karaagac: DOACs vs. VKAs in Cerebral Venous Thrombosis
-
Nov 3, 2026, 12:30Pakeeza Arshad: RDW and Bone Marrow Recovery in Hematological Malignancies
-
Nov 3, 2026, 12:21Mohamed Touhid Patel: Combining Microfluidics and SERS for Advanced Blood Analysis
-
Nov 3, 2026, 12:17Renata Vernay Lopes: Advancing Patient Blood Management and Care at HEMO 2026